Search

everythinglearnresearchcommunity

for

Search:↓

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

The new cream is safe and effective for mild to moderate atopic dermatitis.

WS Biotin, a new form of D-Biotin, improves water solubility and shows potential for hair and skin care without being toxic at low levels.

Hair steroid measurement is an effective method to diagnose and monitor CAH in developing countries.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Tinea capitis in adults often leads to misdiagnosis or delayed diagnosis due to atypical symptoms, requiring careful examination for proper treatment.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Topical corticosteroids are the best initial treatment for children with Alopecia Areata.

The grey patch variant of tinea capitis is most common, mainly spread through family and animals.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Pulse corticosteroid therapy helps many with severe alopecia areata regrow hair, but has side effects.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Tinea capitis in older adults is often misdiagnosed but can be effectively treated with antifungal therapy.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.